Global RHU Albumin Market

Report ID : 1482 | Published : 2022-12-05 | Pages: | Format: PDF/EXCEL

The market size of the Global RHU Albumin Market in the year 2021 is valued at 79.35 million and is predicted to reach 194.61 million by the year 2030 at an 10.65% CAGR during the forecast period.

The recombinant human albumin (rHU Albumin) is structurally similar to native human serum albumin (HSA) but lacks any serum or animal products. rHU Albumin is a non-glycosylated, single-chain polypeptide with a molecular weight of 66 kilo kDa. The albumin market has experienced rapid expansion due to rising immunoglobulin production, increased demand for albumin in research and development, and a surge in albumin's non-therapeutic applications. The main driver of the albumin market's expansion is an increase in the prevalence of rare diseases, shocks, trauma, burns, and other causes of death. Increased awareness of recombinant albumin products, increased awareness of recombinant albumin products, and increased non-therapeutic use of albumin as an excipient and drug-formulating agent are further reasons driving the market's expansion. In addition, many businesses are expanding their market reach to do business in new markets.

Additionally, due to the strong demand for albumin in research and development activities and expanding immunoglobulin production, an increase in albumin's non-therapeutic uses has boosted the market's growth. On the other hand, the market is anticipated that developing cost-effective treatments through large-scale production and significant market potential in undeveloped emerging nations may impede the market's expansion. Nowadays, people are more conscious of their health, which motivates them to maintain it and drives up the demand for albumin in the production of pharmaceuticals. As a result, the albumin market now offers a profitable prospect for growth. This has further encouraged several important businesses to explore emerging countries.

Market Segmentation:

The rHU albumin market is segmented on the source, application and end-use. Based on the source, the rHU albumin market is segmented into oryza sativa, pichia pastoris and others (saccharomyces cerevisiae, etc.). Based on application, the rHU albumin market is segmented into cell culture media (nutrient and stabilize, medium supplement), stem cell therapy, drug formulations, cryopreservation and Others. Based on the end users, the rHU albumin market is segmented into the pharmaceutical & biotechnological industry and research institutes.

Based on applications, the cell culture medium segment is a major contributor to the rHU albumin market.

Cell culture media dominated the industry with the biggest market share. The medium to develop cells frequently contains sufficient energy and chemicals that regulate the cell cycle. A culture medium mostly comprises glucose, serum, inorganic salts, amino acids, and vitamins. Because serum includes growth factors, hormones, and attachment factors, it is added to the medium. The medium helps maintain a consistent pH and osmolality level and provides nutrients to the plant.

The pharmaceutical and biotechnology segment witnessed growth at a rapid rate.

The pharmaceutical and biotechnology sector had the top spot in the global albumin (as excipient) market. Rising R&D efforts for the creation of technologically advanced items, as well as more significant government expenditure, have supported the category's growth. Recombinant human serum albumin is used in the life sciences industry for many different things, including microbial culture media and cell components, growth promoters for recombinant DNA, blocking agents for blotting, and hybridoma technologies. This is predicted to boost the segment's expansion in the coming years.

The North American rHU Albumin market holds a significant regional revenue share.

The North American rHU albumin market is expected to register the highest market share in revenue soon. Due to growth methods followed by market participants, including creating production facilities to broaden their product line, the North American region is anticipated to present a profitable opportunity for the rHU albumin market. Besides, Europe region is accounted to hold a significant share in the market. Due to the need for albumin in research and development, the rising level of immunoglobulin production, the expansion of albumin's non-therapeutic applications, and the increasing rates of plasma collection in the area. Additionally, it is anticipated that rising rHU albumin research and development activity in Europe will fuel market expansion in the area.

Competitive Landscape

Some major key players in the rHU Albumin market are Merck KGaA, HiMedia Laboratories Pvt. Ltd., Albumin Bioscience, Albumedix, ScienCell Research Laboratories, Inc., InVitria, Lazuline Biotech Private Limited, Lee Biosolutions, Inc., Abcam Plc, and Shandong Kingtone Biotechnology Co.,Ltd.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global RHu Albumin Market Snapshot

Chapter 4. Global RHu Albumin Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Source Type Estimates & Trend Analysis

5.1. by Source Type & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Source Type:

5.2.1. Oryza sativa

5.2.2. Pichia pastoris

5.2.3. Others (Saccharomyces cerevisiae, etc.)

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis

6.1. by Application & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

6.2.1. Cell Culture Media

6.2.1.1. Nutrient and stabilizer

6.2.1.2. Medium Supplement

6.2.2. Stem Cell Therapy

6.2.3. Drug Formulations

6.2.4. Cryopreservation

6.2.5. Others

Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis

7.1. by End-user & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by End-user:

7.2.1. Pharmaceutical & Biotechnological Industry

7.2.2. Research Institutes

Chapter 8. RHu Albumin Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2022-2030

8.1.2. North America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.1.3. North America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2030

8.1.4. North America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2022-2030

8.2.2. Europe RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.2.3. Europe RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2030

8.2.4. Europe RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2022-2030

8.3.2. Asia Pacific RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.3.3. Asia-Pacific RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2030

8.3.4. Asia Pacific RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.4. Latin America

8.4.1. Latin America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2022-2030

8.4.2. Latin America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.4.3. Latin America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2030

8.4.4. Latin America RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2022-2030

8.5.2. Middle East & Africa RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.5.3. Middle East & Africa RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2022-2030

8.5.4. Middle East & Africa RHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Merck KGaA

9.2.2. HiMedia Laboratories Pvt. Ltd.

9.2.3. Albumin Bioscience

9.2.4. Albumedix

9.2.5. ScienCell Research Laboratories, Inc.

9.2.6. InVitria

9.2.7. Lazuline Biotech Private Limited

9.2.8. Lee Biosolutions, Inc.

9.2.9. Abcam Plc

9.2.10. Shandong Kingtone Biotechnology Co.,Ltd.

9.2.11. Other Prominent Players

By Source:

  • Oryza sativa
  • Pichia pastoris
  • Others (Saccharomyces cerevisiae, etc.

By Application:

  • Cell Culture Media
    • Nutrient and stabilizer
    • Medium Supplement
  • Stem Cell Therapy
  • Drug Formulations
  • Cryopreservation
  • Others

By End User:

  • Pharmaceutical & Biotechnological Industry
  • Research Institutes

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients